Immunogene Therapy of Recurrent Glioblastoma Multiforme with a Liposomally Encapsulated Replication-Incompetent Semliki Forest Virus Vector Carrying the Human Interleukin-12 Gene – A Phase I/II Clinical Protocol

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Neuro-Oncology

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1023/A:1024979103780
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel developments for applications of alphavirus vectors in gene therapy Review Article

  2004cited by this paper
• Interleukin-12 in anti-tumor immunity and immunotherapy.

  2002cited by this paper
• In situ adenoviral interleukin 12 gene transfer confers potent and long-lasting cytotoxic immunity in glioma

  2002cited by this paper
• IFN-gamma and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy.

  2001cited by this paper
• Enhancement of antitumor immune response in glioma models in mice by genetically modified dendritic cells pulsed with Semliki forest virus-mediated complementary DNA.

  2001cited by this paper
• Alphavirus Vectors: Applications for DNA Vaccine Production and Gene Expression

  2001cited by this paper
• A fresh look at tumor immunosurveillance and immunotherapy

  2001cited by this paper
• Recombinant Semliki forest virus infects and kills human prostate cancer cell lines and prostatic duct epithelial cells ex vivo.

  2000cited by this paper
• Cytokine-secreting tumor cell vaccines.

  2000cited by this paper
• Genetic immunization against cervical carcinoma: induction of cytotoxic T lymphocyte activity with a recombinant alphavirus vector expressing human papillomavirus type 16 E6 and E7

  2000cited by this paper
• Cytokines and Cancer Immunotherapy

  2000cited by this paper
• Surgery for cerebral gliomas: past, present, and future.

  2000cited by this paper
• Inhibition of human lung carcinoma cell growth by apoptosis induction using Semliki Forest virus recombinant particles

  2000cited by this paper
• Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration.

  2000cited by this paper
• Semliki Forest virus vectors for in vitro and in vivo applications

  2000cited by this paper
• Induction of P815 tumor immunity by recombinant Semliki Forest virus expressing the P1A gene

  1999cited by this paper
• Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonography

  1999cited by this paper
• Interleukin-12: basic principles and clinical applications.

  1999cited by this paper
• Cancer therapy using a self-replicating RNA vaccine

  1999cited by this paper
• Use of cellular and cytokine adjuvants in the immunotherapy of cancer

  1998cited by this paper
• The challenge of liposomes in gene therapy

  1998cited by this paper
• Immunostimulatory cytokines in somatic cells and gene therapy of cancer.

  1997cited by this paper
• Regulation of endothelial CD44 expression and endothelium-tumour cell interactions by hepatocyte growth factor/scatter factor.

  1997cited by this paper
• Manipulation of the Semliki Forest virus genome and its potential for vaccine construction

  1996cited by this paper
• Survival in patients with recurrent glioma as a measure of treatment efficacy: prognostic factors following nitrosourea chemotherapy.

  1994cited by this paper
• Ten-year survival among patients with supratentorial astrocytomas grade III and IV.

  1988cited by this paper
• Reoperation in the treatment of recurrent intracranial malignant gliomas.

  1987cited by this paper
• Therapy of adult malignant brain tumors: what have the clinical trials taught us?

  1986cited by this paper

• Arboviruses in Cancer therapy: pros and cons

  2026cites this paper
• Self-amplifying RNA virus vectors for drug delivery

  2025cites this paper
• Advances in Liposomal Interleukin and Liposomal Interleukin Gene Therapy for Cancer: A Comprehensive Review of Preclinical Studies

  2025cites this paper
• Advancements in nanotheranostics for glioma therapy

  2024cites this paper
• Convection-enhanced delivery of immunomodulatory therapy for high-grade glioma

  2023cites this paper
• Alphaviruses in Immunotherapy and Anticancer Therapy

  2022cites this paper
• High Incidence of Intracerebral Hemorrhaging Associated with the Application of Low-Intensity Focused Ultrasound Following Acute Cerebrovascular Injury by Intracortical Injection

  2022cites this paper
• Modernistic and Emerging Developments of Nanotechnology in Glioblastoma-Targeted Theranostic Applications

  2022cites this paper
• Convection-enhanced drug delivery for glioblastoma: a review

  2021cites this paper
• Nanotechnology and Nanocarrier-Based Drug Delivery as the Potential Therapeutic Strategy for Glioblastoma Multiforme: An Update

  2021cites this paper
• Semliki Forest virus-based immunotherapy for cancer

  2020cites this paper
• Poly(lactic-co-glycolic acid) nanoparticle-mediated interleukin-12 delivery for the treatment of diabetic retinopathy

  2019cites this paper
• A concise review of immunotherapy for glioblastoma

  2018cites this paper
• Interested in publishing with us ? Contact book

  2018cites this paper
• Targeted Nanotechnology in Glioblastoma Multiforme

  2017cites this paper
• Oncolytic Alphaviruses in Cancer Immunotherapy

  2017cites this paper
• Gene Therapy in the Nervous System: Failures and Successes.

  2017cites this paper
• Survivin a radiogenetic promoter for glioblastoma viral gene therapy independently from CArG motifs

  2017cites this paper
• Convection-enhanced delivery in glioblastoma: a review of preclinical and clinical studies.

  2017cites this paper
• Replicon RNA Viral Vectors as Vaccines

  2016cites this paper
• Getting into the brain: liposome-based strategies for effective drug delivery across the blood–brain barrier

  2016cites this paper
• Interstitial Chemotherapy for Malignant Gliomas

  2016cites this paper
• Current strategies for targeted delivery of bio-active drug molecules in the treatment of brain tumor

  2015cites this paper
• RNA-based viral vectors

  2015influential citation
• Novel delivery methods bypassing the blood-brain and blood-tumor barriers.

  2015cites this paper
• Focused ultrasound-induced blood–brain barrier opening to enhance interleukin-12 delivery for brain tumor immunotherapy: a preclinical feasibility study

  2015cites this paper
• Computational and Pharmacological Target of Neurovascular Unit for Drug Design and Delivery

  2015cites this paper
• Convection-enhanced delivery to the central nervous system.

  2015cites this paper
• Low pathogenic human enteroviruses as novel anti-cancer agents against malignant glioma

  2014cites this paper
• Oncolytic virotherapy for malignant glioma: translating laboratory insights into clinical practice

  2013cites this paper
• Nanomedicine in cerebral palsy

  2013cites this paper
• Affinity-based Delivery and Reloading of Doxorubicin For Treatment of Glioblastoma Multiforme

  2013cites this paper
• Viral and Non-Viral Gene Therapy for Glioblastoma: New Insights into theTreatment of Malignant Brain Tumors

  2013cites this paper
• Low Dose of IL-12 Stimulates T Cell Response in Cultures of PBMCs Derived from Non Small Cell Lung Cancer Patients *

  2012cites this paper
• Novel Animal Models and Gene Therapy Applications for Glioblastoma Multiforme

  2012cites this paper
• Semliki Forest virus biodistribution in tumor-free and 4T1 mammary tumor-bearing mice: a comparison of transgene delivery by recombinant virus particles and naked RNA replicon

  2012cites this paper
• Targeting the neurovascular unit for treatment of neurological disorders.

  2011cites this paper
• The Use of Convection-Enhanced Delivery with Liposomal Toxins in Neurooncology

  2011cites this paper
• Evaluating the role of IL-12 based therapies in ovarian cancer: a review of the literature

  2011cites this paper
• Studies On The Fluid Mechanics And Mass Transfer In Neural Drug Delivery

  2011cites this paper
• Cancer electrogene therapy with interleukin-12.

  2010cites this paper
• A New Tool for the Navigated Placement of Intracerebral Chemotherapy Catheters

  2010cites this paper
• AntiTumor Mechanism of Recombinant Murine Interleukin-12 Vaccine

  2010cites this paper
• Oncolytic viruses as experimental treatments for malignant gliomas: using a scourge to treat a devil.

  2010cites this paper
• Biologic principles of immunotherapy for malignant gliomas.

  2010cites this paper
• Convection-enhanced delivery of nanocarriers for the treatment of brain tumors.

  2009cites this paper
• Controlled systemic release of interleukin‐12 after gene electrotransfer to muscle for cancer gene therapy alone or in combination with ionizing radiation in murine sarcomas

  2009cites this paper
• Alphaviruses in Gene Therapy

  2009cites this paper
• Adenoviral virotherapy for malignant brain tumors

  2009cites this paper
• Alphavirus M1 induces apoptosis of malignant glioma cells via downregulation and nucleolar translocation of p21WAF1/CIP1 protein

  2009cites this paper
• A safety and efficacy study of local delivery of interleukin-12 transgene by PPC polymer in a model of experimental glioma

  2008cites this paper
• Replication competent Semliki Forest virus prolongs survival in experimental lung cancer

  2008cites this paper
• Therapeutic and prophylactic applications of alphavirus vectors

  2008cites this paper
• Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.

  2008cites this paper
• Flt3L in combination with HSV1-TK-mediated gene therapy reverses brain tumor-induced behavioral deficits.

  2008cites this paper
• Vaccine Immunotherapy for Patients with Glioblastoma Multiforme

  2008cites this paper
• Development of Gene and Virotherapy Against Non-Small Cell Lung Cancer

  2007influential citation
• Oncolytic viruses in cancer therapy

  2007cites this paper
• Adenoviral Gene Delivery to Solid Tumors by Recombinant Silk–Elastinlike Protein Polymers

  2007cites this paper
• Immunotherapy for patients with malignant glioma: from theoretical principles to clinical applications

  2006cites this paper
• Clinical applications of virosomes in cancer immunotherapy

  2006cites this paper
• Convection-Enhanced Drug Delivery: Porous Media Models and Microfluidic Devices

  2006cites this paper
• Review: Novel Nonviral Delivery Approaches for Interleukin-12 Protein and Gene Systems: Curbing Toxicity and Enhancing Adjuvant Activity

  2006cites this paper
• Prostate Tumor Cells Infected with a Recombinant Influenza Virus Expressing a Truncated NS1 Protein Activate Cytolytic CD8+ Cells To Recognize Noninfected Tumor Cells

  2006cites this paper
• Various targeted viral and nonviral therapies in brain tumors Vehicle Immunogenicity Advantages Disadvantages

  2005cites this paper
• Regression of mouse tumours and inhibition of metastases following administration of a Semliki Forest virus vector with enhanced expression of IL-12

  2005cites this paper
• Local delivery of antineoplastic agents by controlled-release polymers for the treatment of malignant brain tumours

  2005cites this paper
• Biology and application of alphaviruses in gene therapy

  2005cites this paper
• Regulatable gene expression systems for gene therapy applications: progress and future challenges.

  2005cites this paper
• Cationic liposomes for gene delivery

  2005influential citation
• Review Article Past, present and future perspectives of genetic therapy in gliomas

  2005cites this paper
• Genetic therapy in gliomas: historical analysis and future perspectives.

  2005cites this paper
• Interleukin‐12 gene therapy for hepatocellular carcinoma: A dream come true?

  2004cites this paper
• Lipoplex-mediated delivery of nucleic acids: factors affecting in vivo transfection

  2004cites this paper
• Gene Therapy Applications of Viral Vectors

  2004cites this paper
• Brain Tumor Immunotherapy: An Immunologist's Perspective

  2004cites this paper
• Oncotargets and Therapy Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Dovepress Targeted Therapy in the Treatment of Malignant Gliomas

  year unknowncites this paper